Literature DB >> 23774296

Autophagy in tumour cell death.

Robin L Macintosh1, Kevin M Ryan.   

Abstract

In every moment of a cell's existence one key question is always asked, "To be or not to be"? Cells constantly weigh up signals from their environment against their own integrity and metabolic status and decide whether to live or die. Such cell death decisions are central to the progression and treatment of cancer. The term autophagy describes three processes that deliver cytoplasmic macromolecules and organelles to lysosomes for degradation, the difference between each form being the method of delivery. The most extensively studied form is macroautophagy (hereafter referred to as autophagy) where cytosolic components are engulfed by double membraned autophagosomes. Autophagosomes fuse with lysosomes to form structures called autolysosomes, within which organelles, proteins and other macromolecules are degraded by catabolic enzymes in the acidic lysosome environment. Autophagy, which normally occurs at low levels in unstressed cells, is widely regarded as having a positive effect on cell health as potentially harmful protein aggregates and damaged organelles can be recycled. During periods of nutrient shortage autophagy is enhanced to provide, albeit temporarily, an internal energy source. Autophagy is also enhanced by other stresses encountered by tumour cells and this may protect the cell or aid its demise. In this review we examine the effect of autophagy on cell death decisions in tumour cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; CML; CQ; CTL; Cancer; Cell death; DAMP; ECM; HDACi; MOMP; PDAC; RCC; ROS; SAHA; TKi; chloroquine; chronic myeloid leukaemia; cytotoxic T-lymphocyte; danger-associated molecular pattern; extracellular matrix; histone deacetylase inhibitor; mitochondrial outer membrane permiabilisation; pancreatic ductal adenocarcinoma; reactive oxygen species; renal cell carcinoma; suberoylanilide hydroxamic acid; tyrosine kinase inhibitor

Mesh:

Year:  2013        PMID: 23774296     DOI: 10.1016/j.semcancer.2013.05.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  53 in total

1.  Autophagy is associated with cucurbitacin D-induced apoptosis in human T cell leukemia cells.

Authors:  Tsukasa Nakanishi; Yuan Song; Cuiying He; Duo Wang; Kentaro Morita; Junichi Tsukada; Tamotsu Kanazawa; Yasuhiro Yoshida
Journal:  Med Oncol       Date:  2016-02-25       Impact factor: 3.064

Review 2.  Development of autophagy inducers in clinical medicine.

Authors:  Beth Levine; Milton Packer; Patrice Codogno
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

3.  The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.

Authors:  Qian-Xia Li; Xiao Zhou; Ting-Ting Huang; Yang Tang; Bo Liu; Ping Peng; Li Sun; Yi-Hua Wang; Xiang-Lin Yuan
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 4.  Arginine dependence of tumor cells: targeting a chink in cancer's armor.

Authors:  M D Patil; J Bhaumik; S Babykutty; U C Banerjee; D Fukumura
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

Review 5.  Translational regulator eIF2α in tumor.

Authors:  Qiaoli Zheng; Jingjia Ye; Jiang Cao
Journal:  Tumour Biol       Date:  2014-03-09

Review 6.  Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.

Authors:  Alan J Fowler; Charbel E-H Moussa
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

Review 7.  Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.

Authors:  Pavan P Adiseshaiah; Rachael M Crist; Sara S Hook; Scott E McNeil
Journal:  Nat Rev Clin Oncol       Date:  2016-08-17       Impact factor: 66.675

Review 8.  Glutaminolysis and autophagy in cancer.

Authors:  Victor H Villar; Faten Merhi; Mojgan Djavaheri-Mergny; Raúl V Durán
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

9.  w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway.

Authors:  Pinghu Zhang; Zuguo Zheng; Li Ling; Xiaohui Yang; Ni Zhang; Xue Wang; Maozhi Hu; Yu Xia; Yiwen Ma; Haoran Yang; Yunyi Wang; Hongqi Liu
Journal:  Autophagy       Date:  2017-05-17       Impact factor: 16.016

10.  Role of caspase-10 in the death of acute leukemia cells.

Authors:  Wenjian Guo; Aishu Dong; Xiahui Pan; Xiaoji Lin; Ying Lin; Muqing He; Baoling Zhu; Liming Jin; Rongxing Yao
Journal:  Oncol Lett       Date:  2016-06-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.